XPH Holdings
State Street SPDR S&P Pharmaceuticals ETF
1W: -3.7%
1M: -11.0%
3M: -5.4%
YTD: +15.3%
1Y: +31.1%
3Y: +63.7%
5Y: +39.5%
$63.64
-0.14 (-0.22%)
Weekly Expected Move ±3.1%
$60
$62
$64
$66
$68
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$257M
Holdings61
Top 10 Wt21.7%
Beta0.72
% Profitable39%
Coverage97%
Portfolio Valuation
P/E35.7
P/B7.8
P/S6.1
EV/EBITDA21.3
P/FCF28.6
PEG2.51
Profitability & Returns
Gross Margin72.0%
Net Margin15.8%
ROE20.9%
ROA7.4%
ROIC16.2%
Div Yield0.67%
Leverage & Liquidity
Debt/Equity1.01
Debt/Assets0.36
Net Debt/EBITDA1.9x
Interest Cov9.7x
Current Ratio1.39
Quick Ratio1.07
Growth (YoY)
Revenue+34.4%
Net Income+35.7%
EPS+42.4%
FCF+29.2%
EBITDA+35.7%
Rev CAGR 3Y+68.4%
Quality Scores
Piotroski F5.0
Altman Z14.78
IS Quality57.2
IS Overall50.3
IS Value43.9
Median P/E-1.8
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 61 | 100.0% | 4.4 |
| Other | 3 | 0.1% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 64 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | XERIS BIOPHARMA HOLDINGS INC | XERS | 2.46% | $13.3M | 1,342,332 | -93.5 | $1.6B | Healthcare |
| 2 | VERADERMICS INC | MANE | 2.42% | $13.1M | 103,838 | — | $4.9B | Healthcare |
| 3 | AMNEAL PHARMACEUTICALS INC | AMRX | 2.32% | $12.5M | 599,966 | 40.8 | $6.5B | Healthcare |
| 4 | LIGAND PHARMACEUTICALS | LGND | 2.16% | $11.6M | 35,927 | 30.3 | $6.1B | Healthcare |
| 5 | VIATRIS INC | VTRS | 2.13% | $11.5M | 627,234 | -48.9 | $20.5B | Healthcare |
| 6 | INDIVIOR PHARMACEUTICALS INC | INDV | 2.05% | $11.1M | 297,653 | 12.6 | $4.5B | Healthcare |
| 7 | PERRIGO CO PLC | PRGO | 2.05% | $11.1M | 721,712 | -1.1 | $2.0B | Healthcare |
| 8 | ELI LILLY + CO | LLY | 2.05% | $11.1M | 9,204 | 38.2 | $1.1T | Healthcare |
| 9 | ANI PHARMACEUTICALS INC | ANIP | 2.04% | $11.0M | 146,386 | 14.9 | $1.6B | Healthcare |
| 10 | PFIZER INC | PFE | 2.04% | $11.0M | 372,550 | 36.7 | $158.4B | Healthcare |
| 11 | SUPERNUS PHARMACEUTICALS INC | SUPN | 2.03% | $11.0M | 246,005 | -22.1 | $2.5B | Healthcare |
| 12 | INNOVIVA INC | INVA | 2.00% | $10.8M | 489,796 | 4.2 | $1.5B | Healthcare |
| 13 | ORGANON + CO | OGN | 1.99% | $10.8M | 757,086 | 17.4 | $3.6B | Healthcare |
| 14 | DEFINIUM THERAPEUTICS INC | DFTX | 1.99% | $10.8M | 272,425 | -10.9 | $5.0B | Healthcare |
| 15 | CORCEPT THERAPEUTICS INC | CORT | 1.98% | $10.7M | 89,452 | 223.5 | $12.6B | Healthcare |
| 16 | JOHNSON + JOHNSON | JNJ | 1.97% | $10.6M | 38,752 | 29.6 | $617.0B | Healthcare |
| 17 | MERCK + CO. INC. | MRK | 1.96% | $10.6M | 70,149 | 114.5 | $356.4B | Healthcare |
| 18 | MAZE THERAPEUTICS INC | MAZE | 1.96% | $10.6M | 374,631 | -9.6 | $1.5B | Healthcare |
| 19 | OMEROS CORP | OMER | 1.95% | $10.5M | 533,750 | 9.7 | $1.3B | Healthcare |
| 20 | BRISTOL MYERS SQUIBB CO | BMY | 1.93% | $10.4M | 160,678 | 13.5 | $124.9B | Healthcare |
| 21 | SEPTERNA INC | SEPN | 1.92% | $10.4M | 254,932 | -69.8 | $1.7B | Healthcare |
| 22 | ROYALTY PHARMA PLC CL A | RPRX | 1.91% | $10.3M | 170,810 | 23.7 | $25.3B | Healthcare |
| 23 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1.91% | $10.3M | 42,889 | 15.5 | $14.8B | Healthcare |
| 24 | ZOETIS INC | ZTS | 1.89% | $10.2M | 141,171 | 11.5 | $29.2B | Healthcare |
| 25 | ELANCO ANIMAL HEALTH INC | ELAN | 1.89% | $10.2M | 439,463 | -54.0 | $11.1B | Healthcare |
| 26 | TARSUS PHARMACEUTICALS INC | TARS | 1.89% | $10.2M | 125,037 | -67.0 | $3.1B | Healthcare |
| 27 | HARMONY BIOSCIENCES HOLDINGS | HRMY | 1.87% | $10.1M | 248,663 | 12.7 | $2.3B | Healthcare |
| 28 | PRESTIGE CONSUMER HEALTHCARE | PBH | 1.87% | $10.1M | 212,512 | 12.6 | $2.1B | Healthcare |
| 29 | EDGEWISE THERAPEUTICS INC | EWTX | 1.86% | $10.1M | 238,522 | -22.4 | $4.5B | Healthcare |
| 30 | MBX BIOSCIENCES INC | MBX | 1.85% | $10.0M | 164,509 | -24.4 | $2.8B | Healthcare |
| 31 | COLLEGIUM PHARMACEUTICAL INC | COLL | 1.81% | $9.8M | 432,687 | 14.4 | $714M | Healthcare |
| 32 | AMYLYX PHARMACEUTICALS INC | AMLX | 1.79% | $9.6M | 319,426 | -19.7 | $3.1B | Healthcare |
| 33 | AXSOME THERAPEUTICS INC | AXSM | 1.74% | $9.4M | 49,136 | -47.8 | $9.2B | Healthcare |
| 34 | ETON PHARMACEUTICALS INC | ETON | 1.74% | $9.4M | 175,920 | 119.1 | $1.5B | Healthcare |
| 35 | PACIRA BIOSCIENCES INC | PCRX | 1.74% | $9.4M | 360,702 | 71.6 | $992M | Healthcare |
| 36 | TREVI THERAPEUTICS INC | TRVI | 1.71% | $9.2M | 621,957 | -41.2 | $2.0B | Healthcare |
| 37 | NUVATION BIO INC | NUVB | 1.71% | $9.2M | 1,587,327 | -11.8 | $1.8B | Healthcare |
| 38 | HARROW INC | HROW | 1.63% | $8.8M | 275,617 | -30.7 | $1.1B | Healthcare |
| 39 | ENLIVEN THERAPEUTICS INC | ELVN | 1.59% | $8.6M | 180,148 | -28.6 | $3.4B | Healthcare |
| 40 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 1.55% | $8.4M | 311,762 | 14.6 | $1.1B | Healthcare |
| 41 | ZEVRA THERAPEUTICS INC | ZVRA | 1.54% | $8.3M | 730,488 | 10.4 | $591M | Healthcare |
| 42 | ALUMIS INC | ALMS | 1.50% | $8.1M | 1,056,059 | -1.8 | $846M | Healthcare |
| 43 | RAPPORT THERAPEUTICS INC | RAPP | 1.41% | $7.6M | 219,100 | -10.6 | $1.5B | Healthcare |
| 44 | LB PHARMACEUTICALS INC | LBRX | 1.38% | $7.5M | 187,105 | -12.5 | $1.1B | Healthcare |
| 45 | WAVE LIFE SCIENCES INC | WVE | 1.37% | $7.4M | 1,924,591 | -3.5 | $745M | Healthcare |
| 46 | OCULAR THERAPEUTIX INC | OCUL | 1.33% | $7.2M | 902,298 | -4.9 | $1.5B | Healthcare |
| 47 | CORMEDIX INC | CRMD | 1.26% | $6.8M | 849,168 | 3.0 | $564M | Healthcare |
| 48 | ALTO NEUROSCIENCE INC | ANRO | 1.23% | $6.7M | 251,090 | -10.0 | $870M | Healthcare |
| 49 | PHIBRO ANIMAL HEALTH CORP A | PAHC | 1.17% | $6.3M | 170,408 | 15.1 | $1.5B | Healthcare |
| 50 | AQUESTIVE THERAPEUTICS INC | AQST | 1.16% | $6.3M | 1,305,009 | -7.0 | $571M | Healthcare |